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Abstract 
Magnetic resonance imaging (MRI) is a non-invasive imaging technique that has emerged as 
one of the most powerful diagnostic tools in clinical medicine. Paramagnetic contrast agents 
(CAs), usually Gd-chelates, are often employed during an MRI scan to achieve better image 
contrast between a diseased and normal tissue. They work by modulating the longitudinal and 
transverse relaxation times of water protons within the tissues. Most of the current 
commercially available CAs, which can be broadly classified as low molecular weight CAs, 
are small, fast reorientating molecules with restricted specificity and targeting ability and 
relatively moderate efficiency (called relaxivity in the case of MRI CAs). Also, there have 
been reports linking their use with nephrogenic systemic fibrosis, a serious disorder that 
occurs in patients with chronic kidney disease and acute renal failure. The suspected cause is 
the dissociation of the Gd-ligand complex due to their slow clearance as a result of renal 
failure, suggesting the need for more stable CAs. This has spurred interest in developing 
stable high molecular weight CAs. Such CAs possess slow molecular reorientation, resulting 
in much better contrast activities compared to their low molecular weight counterparts. They 
are also passively targeted towards tumours due to enhanced permeation and retention. A 
useful approach for increasing the molecular weight (or size) of MRI CAs is to impart 
amphiphilic character to them and let them self-assemble to form supramolecular 
nanoparticles (hereafter called nanoassemblies) upon dispersion in an aqueous solution. 
Supramolecular MRI CAs have all the benefits of high molecular weight CAs and can also 
provide high payloads of Gd(III) ions at the target site.  
In this thesis, highly ordered supramolecular nanoassemblies, made of paramagnetic 
amphiphilic chelates, were developed and investigated as advanced MRI CAs. To begin with, 
relaxation theory based on the dipolar and scalar relaxation mechanisms in the two spin 
system was pedagogically (re)derived to understand the theoretical framework of a 
paramagnetic MRI CA. Based on this, novel paramagnetic amphiphilic chelates were 
designed and synthesised with the ability to form lamellar or inverse bicontinuous cubic 
nanoassemblies by themselves. Selected paramagnetic amphiphiles were also incorporated, at 
various concentrations, within non-ionic external lipid matrices to assist the formation of 
highly ordered mesophases. Differential scanning calorimetry, thermogravimetric analysis, 
polarised optical microscopy and synchrotron small angle X-ray scattering (SAXS) were 
employed to characterise the neat amphiphiles and examine the self-assembly structures of 
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their bulk phases. Upon dispersion in an aqueous solution, cryogenic transmission electron 
microscopy, variable temperature SAXS, and dynamic light scattering were used to 
investigate the morphology, structure and size of the dispersed nanoassemblies.  
To assess their potential as MRI CAs, the in-vitro relaxivities of the nanoassemblies were 
measured at various magnetic field strengths (ranging from 0.47 – 11.74 T) and in some 
cases, contrast enhancement was directly observed by performing in-vitro MRI experiments. 
For nanoassemblies made solely from the paramagnetic amphiphiles, molecular parameters 
such as reorientational correlation time and water exchange rate were determined by 
comparing the theoretical models to the variable temperature 
17
O transverse relaxation time 
measurements, and the variable magnetic field 
1
H longitudinal relaxation time measurements 
(also known as nuclear magnetic relaxation dispersions profiles).  
It was found that paramagnetic amphiphilic chelates containing branched hydrophobic chains 
can be incorporated at a higher concentration within the inverse bicontinuous cubic phases of 
an external lipid compared to paramagnetic amphiphilic chelates with unsaturated 
unbranched chains. In general, the in-vitro relaxivities (and in some cases image contrast) of 
the nanoassemblies were found to be higher than Magnevist, a commercially available CA, at 
both low and high magnetic field strengths. The nanoassemblies made of mixed amphiphiles 
(paramagnetic amphiphilic chelates and non-ionic external lipids) showed better relaxivities 
than those made solely from paramagnetic amphiphiles at high magnetic field strength.  
Liposomal nanoassemblies made from sole paramagnetic amphiphiles with branched chains 
and monoamide conjugates as the chelating head groups showed faster water exchange than 
the previously reported paramagnetic liposomes (with unbranched chains and bisamide 
conjugates as head groups). Nevertheless, their relaxation enhancement was still found to be 
limited by water exchange. Improved relaxivities were largely due to the slow molecular 
reorientation. 
Finally, a novel and efficient method of determining relaxivities was also developed. 
According to this method, relaxivity of a paramagnetic MRI CA can be determined by 
relating the two NMR observables: induced chemical shifts and enhanced relaxation rates, 
both of which are dependent on the concentration of the paramagnetic MRI CA. 
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Selected Abbreviations and Symbols 
In this thesis, vector quantities are written in bold. 
Abbreviation Name 
CA contrast agent 
CPMG Carr-Purcell-Meiboom-Gill 
CPP critical packing parameter 
Cryo-TEM cryogenic transmission electron microscopy 
CSA chemical shift anisotropy 
CT computed tomography 
DCM dichloromethane 
DD dipole-dipole 
DLS dynamic light scattering 
DSC differential scanning calorimetry 
DTPA diethylenetriaminepentaacetic acid 
DTPA-BO DTPA-bisoleyl 
DTPA-BP DTPA-bisphytanyl 
DTPA-DOP-Phy DTPA-dopamine-bisphytanyl 
DTPA-MO DTPA-monooleyl 
DTPA-MP DTPA-monophytanyl 
EDTA ethylenediaminetetraacetic acid 
ELSD evaporative light scattering detector 
EPR enhanced permeation and retention 
FFC fast field cycling 
FID free induction decay 
FLASH fast low angle shot 
GMO glycerol monooleyl 
HPLC high performance liquid chromatography 
ICP-OES inductively coupled plasma optical emission spectrometry 
IS inner sphere 
MRI magnetic resonance imaging 
MS mass spectroscopy 
NMR nuclear magnetic resonance 
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NMRD nuclear magnetic relaxation dispersion 
NSF nephrogenic systemic fibrosis 
OS outer sphere 
PET positron emission tomography 
POM polarised optical microscopy 
PT phytantriol 
QR quadrupolar relaxation 
rf radio frequency 
SAXS small angle X-ray scattering 
SBM Solomon-Bloembergen-Morgan 
SC scalar 
SPECT single photon emission computed tomography 
SPIO superparamagnetic iron oxide 
SR spin rotation 
SS second sphere 
TGA thermogravimetric analysis 
ZFS zero field splitting 
  
Symbol Definition 
a surface area of the head-group 
A/ħ  electron nuclear hyperfine coupling constant  
B0 static magnetic field  
B1 excitation field 
C contrast factor 
d distance of closest approach between the outer sphere solvent nuclei 
and the paramagnetic complex 
D translational diffusion coefficient 
∆ trace of the square of the zero field splitting tensor 
g electronic g factor 
G magnetic gradient 
Gf frequency encoding gradient 
Gφ phase encoding gradient 
Gz slice selection gradient 
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j(ω)  spectral density at angular frequency ω 
k Boltzmann’s constant  
kex solvent exchange rate 
l length of the hydrophobic chains 
M0 net magnetisation 
NA Avogadro’s number 
φ phase of the signal 
ρ spin density 
P surfactant parameter 
Pm mole fraction of the metal-bound solvent nuclei 
q hydration number 
r distance between solvent protons and paramagnetic complex  
r1 spin-lattice or longitudinal relaxivity 
r2 spin-spin or transverse relaxivity 
S spin angular momentum 
S(k) signal in k-space 
Sc(k) modified signal 
S(t) acquired signal 
T1 spin-lattice relaxation decay constant 
T2 spin-spin relaxation decay constant 
T2 inhomogeneous inhomogeneous spin-spin relaxation time 
Tie electronic relaxation rate 
TE echo time 
TR repetition time 
τ interval between pulses 
τc correlation time 
τD diffusional correlation time 
τm water residency time 
τR reorientational correlation time 
τv correlation time of zero field splitting 
μ magnetic moment 
μB Bohr magneton 
μ0 magnetic constant 
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v volume of the hydrophobic chains 
ω0 Larmor frequency 
ωI nuclear Larmor frequency 
ωs electron Larmor frequency 
γ gyromagnetic ratio 
γI nuclear gyromagnetic ratio 
γs electronic gyromagnetic ratio 
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Chapter 1. Introduction – Contrast Agents 
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Cancer is a leading cause of death worldwide. According to GLOBOCAN 2012 estimates, 
8.2 million cancer deaths and 14.07 million new cancer cases are estimated to have occurred 
worldwide in 2012.
1, 2
 A significant proportion of the global burden of this devastating 
disease can be prevented by early detection and treatment of primary tumours.
3
 Many 
imaging modalities such as ultrasound imaging,
4
 X-ray computed tomography (CT), single 
photon emission computed tomography (SPECT)
5
 and positron emission tomography (PET)
6
 
have been employed, but magnetic resonance imaging (MRI) has emerged as the most 
promising technique in diagnostic clinical medicine.
7
 It is a non-invasive imaging technique 
which relies on the principles of nuclear magnetic resonance (NMR) and offers excellent 
spatial resolution without using any harmful radiation.
8, 9
 
For diagnostic purposes, it is important to be able to differentiate diseased tissue from the 
neighbouring normal tissue. This requires the two tissue types to possess different properties 
that will result in different signals being detected by the imaging method. This difference in 
the signals from the two tissues of interest is called ‘contrast’.8 Like any other imaging 
modality, image contrast in MRI is of utmost importance to diagnose abnormalities. There 
are three parameters which largely conduce to image contrast in MRI, namely the spin 
density and the longitudinal (T1) and transverse relaxation times (T2). Spin density refers to 
the number of nuclei in a given voxel (3D pixel), so higher the spin density higher the signal 
intensity in an MRI image. The physical meaning of the relaxation times is explained in 
Chapter 2. For now, it should suffice to know that they are nucleus-dependent observables for 
NMR (and MRI). More details on MRI contrast are discussed in Section 3.5. 
Clinically, the naturally occurring contrast between the tissues is often insufficient, especially 
in complicated cases such as for detection of primary tumours. This gives rise to the need of 
contrast enhancement which is achieved by injecting chemicals known as contrast 
enhancement agents or contrast agents (CAs) (Figure 1). Typically, CAs modulate the 
relaxation times of water protons inside the tissues to provide enhanced image contrast. 
Based on this, the efficiency of an MRI CA, termed relaxivity (r1 or r2), is defined as the 
change in the relaxation rate of water protons upon the addition of a CA, normalised to its 
concentration, as given by 
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 ii
(1/ )
;          1,2.
[CA]

 
T
r i   (1) 
All CAs increase both r1 and r2 to varying degrees, depending on whether they are 
categorised as negative or positive CAs.  
 
 
Figure 1: NMR images of the brain of a patient before (left) and after (right) the intravenous injection of 
Magnevist, a commercially available contrast agent. The tumour (encircled red) is visible in the image with 
Magnevist. Reprinted (adapted) with permission from ref.
10
 ©1987 American Chemical Society. 
 
1.1 Negative or T2 Contrast Agents 
Negative CAs, also known as T2 CAs, reduce T2 a lot more than T1 and can, therefore, have 
r2/r1 as high as 10 or more.
11
 These CAs are mostly made from superparamagnetic iron oxide 
(SPIO), with the general formula Fe2
3+
O3M
2+
O, where M
2+
 is a divalent ion such as iron, 
manganese, nickel, cobalt, or magnesium. If the metal ion (M
2+
) is ferrous (Fe
2+
), the SPIO is 
magnetite. Negative CAs, as the name indicates, induce negative contrast in an MRI image 
by decreasing the signal intensity of the affected water protons.
12, 13
 Further details on 
negative CAs are outside the scope of this thesis, but can be found elsewhere.
13, 14
  
1.2 Positive or T1 Contrast Agents 
Positive or T1 CAs usually have r2/r1 ≅ 1–2. These CAs mainly comprise paramagnetic metal 
ions chelated to multi-dentate ligands. Upon injection, they induce positive contrast by 
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increasing the signal intensity of the affected water protons. That is, they produce images 
which exhibit hyper-intense regions, indicating agent accumulation and are therefore more 
commonly used in clinics.
10, 15
  
Gd(III), a highly symmetric lanthanide element with seven unpaired electrons, is the most 
commonly employed paramagnetic metal ion in positive MRI CAs.
16, 17
 However, due to the 
toxicity of free Gd(III) ions, they need to be sequestered within chelating reagents so that 
they remain chelated in the body and are excreted intact.
18
 Gd(III) has been known to form 
stable chelates with ethylenediaminetetraacetic acid (EDTA), diethylenetriaminepentaacetic 
acid (DTPA) and 1,4,7,10 tetraazacyclododecane-N,N,N,N-tetraacetic acid (DOTA).
19
 
Positive CAs can be further divided into two categories dependent on their molecular weight 
(or size): low and high molecular weight CAs, as discussed below. 
1.3 Low Molecular Weight Contrast Agents 
Most of the current commercially available CAs are the linear DTPA-type or cyclic DOTA-
type complexes of Gd(III) (Figure 2). Such CAs, which can be broadly classified as low 
molecular weight CAs, are small, fast reorientating molecules with restricted specificity and 
targeting ability and relatively moderate relaxivities. Moreover, there have been some reports 
linking their use with nephrogenic systemic fibrosis, a serious disorder that occurs in patients 
with chronic kidney disease and acute renal failure.
20-22
 The suspected cause is the 
dissociation of the Gd-ligand complex due to their prolonged clearance as a result of renal 
failure, suggesting the need for more stable CAs.
20
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Figure 2: Structures of some commercially available MRI contrast agents.
17, 23-29
 
 
1.4 High Molecular Weight Contrast Agents 
Stable target specific CAs with high relaxivity are desired in MRI to get better contrast at low 
doses.
30
 A number of factors (or relaxation parameters) affect the relaxivity of a CA such as 
the reorientational correlation time of the molecule (τR), mean water residency time (τm), 
electronic relaxation times (T1e or T2e) and hydration number (q) (Figure 3; further details on 
these parameters and general relaxation theory are discussed in Chapter 4).
30
 One of the 
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common strategies used to increase the relaxivity is to slow down the molecular reorientation 
of the contrast agents (long τR) by increasing their molecular size (or weight).
11
 High 
molecular weight CAs are also passively targeted to diseased tissues (such as tumours) 
through the enhanced permeation and retention effect.
31
  
 
 
Figure 3: A schematic representation of a Gd-chelate coordinated to one water molecule. τR refers to the 
reorientational correlation time of the molecule, τm is the lifetime of the water molecule coordinated to the 
Gd(III) ion (inverse of the water exchange rate, kex), q indicates the number of water molecules directly 
coordinated to the Gd(III) ions, also known as the hydration number, and Tie is the relaxation time of the 
electron spin of the Gd(III) ion. 
 
The high molecular weight CAs can be made in two ways which are discussed below. 
1.4.1 Macromolecular Contrast Agents 
Macromolecular CAs are made by attaching the low molecular weight Gd-chelates to large 
molecules such as proteins and polymers
32, 33
 or by incorporating them within dendrimers,
34
 
nanotubes,
35
 fullerenes,
36
 and zeolites
37
 (Figure 4a). In this way, the molecular reorientation 
of the contrast agent is restricted (reduced), thus resulting in longer τR and higher relaxivities.  
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Figure 4: Schematic representation of the two different ways of developing high molecular weight CAs to 
reduce their molecular tumbling (and increase τR). (a) Macromolecular CAs are made by conjugating low 
molecular weight Gd-chelates to macromolecules (such as proteins and dendrimers) and (b) supramolecular 
CAs are made by imparting amphiphilic character to the Gd-chelates, by attaching one or more alkyl or 
phospholipid chains to them, and letting them self-assemble to form various lyotropic liquid crystalline 
structures. Supramolecular CAs can deliver much higher payloads of Gd(III) ions than the macromolecular CAs. 
 
1.4.2 Supramolecular Contrast Agents 
Supramolecular CAs are made by imparting the amphiphilic character to the Gd-chelates 
(head-group), by attaching one or more alkyl or phospholipid chains to them, and allowing 
them to self-assemble into various lyotropic liquid crystalline structures (Figure 4b).
38, 39
 
Examples of some paramagnetic amphiphilic chelates are Gd-DTPA-monophytanyl (Gd-
DTPA-MP) and Gd-DTPA-bisphytanyl (Gd-DTPA-BP), as shown in Figure 5.
40, 41
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Figure 5: The chemical structures of two paramagnetic amphiphiles. The Gd-DTPA head-group has one 
negative charge in Gd-DTPA-MP and is neutral in Gd-DTPA-BP.  
 
The length, l, and volume, v, of the hydrophobic chains and the surface area, a, of the 
hydrophilic head-group can all vary in the amphiphilic molecules. Depending on these 
charactersitics, the local geometry of the liquid crystalline structures can be roughly 
estimated from the critical packing parameter, CPP, given by
42
 
 .
v
CPP
al
   (2) 
Amphiphiles with CPP < 1 tend to form structures that are curved towards the hydrocarbon 
chain (called normal or type 1 mesophases) such as micellar, normal hexagonal and cubic 
phases. Amphiphiles with CPP ≈ 1 leads to flat structures like planar lamellar or vesicles due 
to the balance between the sizes of head-group and tail and CPP > 1 tend to form structures 
that are curved towards water (called inverse or type 2 mesophases) such as inverse 
bicontinuous cubic, inverse hexagonal or inverse micellar structures (Figure 6).
43
 The 
lamellar and inverse mesophases are thermodynamically stable in excess water and can also 
be dispersed to submicron sized colloidal nanoparticles (hereafter called nanoassemblies) in 
the presence of an aqueous solution, using shear forces, and stabilised by an adsorbed 
polymer.
44
 Such supramolecular nanoassemblies (liposomes, hexosomes and cubosomes) 
made from the paramagnetic amphiphiles possess ideal properties to be explored as advanced 
MRI CAs. For example, apart from the previously discussed advantages of high molecular 
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weight CAs, supramolecular nanoassemblies of paramagnetic amphiphiles also offer high 
payloads of the coordinated Gd(III) ions and extensive water channels which may offer a 
better environment for diffusion and allow fast water exchange (short τm), resulting in 
improved relaxivities as MRI CAs. Furthermore, the higher order inverse mesophases have 
also been shown to be stable drug delivery systems and thus also possess the potential to be 
used as carriers for MRI CAs.
45-47
  
 
 
Figure 6: A schematic representation of the liquid crystalline structures of the amphiphilic molecules with 
different critical packing parameters (CPP = v/al). Amphiphiles with CPP < 1 tend to form normal (type 1) 
structures such as hexagonal and cubic phase, CPP ≈ 1 form flat structures like lamellar and vesicles due to the 
balance between the head-group and tail and CPP > 1 form inverse (type 2) structures such as inverse hexagonal 
and inverse bicontinuous cubic phase. Reproduced with permission from Paper III. 2015 © Wiley-VCH Verlag 
GmbH & Co. KgaA. 
 
1.5 Aims and Objectives 
With the ultimate aim of developing advanced MRI CAs with high relaxivity, (passive) 
targeting and specificity, and a high payload of Gd(III) ions, the following objectives were set 
in this project: (i) design and synthesise novel paramagnetic amphiphiles capable of self-
assembling into highly ordered supramolecular nanoassemblies, (ii) evaluate their 
physicochemical properties and characterise their liquid crystalline structures in the bulk 
phase and on dispersion into an aqueous solution, (iii) investigate the potential of the 
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supramolecular nanoassemblies of the novel paramagnetic amphiphiles as MRI CAs at 
various magnetic field strengths and (iv) determine the effect of their nanostructures on the 
molecular (or relaxation) parameters such as water exchange rate and reorientational 
correlation time. To achieve these objectives, a holistic approach was used and the project 
was performed in four different phases.  
The first phase was to study and comprehend the various relaxation mechanisms which lead 
to contrast enhancement in the presence of paramagnetic CAs. This also entailed the detailed 
(re)derivation of the relevant NMR relaxation theory to develop a theoretical model for MRI 
CAs and to understand the effect of different correlation times on relaxivities. 
The second phase dealt with the design and synthesis of supramolecular paramagnetic 
amphiphiles. In this phase, two strategies were implemented. In one strategy, paramagnetic 
amphiphilic chelates, made by attaching a nonpolar oleyl or phytanyl chain to the DTPA 
head-group, were incorporated at various concentrations within the external inverse 
bicontinuous cubic mesophase forming amphiphiles such as glycerol monooleyl or 
phytantriol. This provided verification of the potential of these mesophases as carriers for 
MRI CAs and also allowed the assessment of the highest concentration of paramagnetic 
amphiphile that can be incorporated without disrupting the cubic mesophases of an external 
matrix. In the second strategy, novel amphiphilic chelates with relatively higher CPP were 
designed and synthesised in an attempt to obtain supramolecular nanoassemblies made solely 
of paramagnetic amphiphiles.  
In the third phase of the project, first the neat amphiphile and their bulk phases were 
characterised using polarised optical microscopy (POM), differential scanning calorimetry 
(DSC), thermogravimetric analysis (TGA) and small angle X-ray scattering (SAXS). Then, 
after dispersion into an aqueous solution, the morphology, structure and size of the dispersed 
nanoassemblies were examined using SAXS, cryogenic transmission electron microscopy 
(Cryo-TEM) and dynamic light scattering (DLS).  
In the fourth and final phase, the potential of the novel nanoassemblies as advanced MRI CAs 
was evaluated by measuring their in-vitro relaxivities at various magnetic field strengths and 
in some cases, by performing in-vitro MRI imaging to directly observe the image contrast 
enhancement. In this last phase, for the nanoassemblies made solely of the paramagnetic 
amphiphiles, the relaxation parameters were also determined by comparing the developed 
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theoretical models to the measured plots of 
17
O NMR transverse relaxation rates as a function 
of temperature and 
1
H NMR longitudinal relaxation rates as a function of magnetic field 
(usually known as nuclear magnetic relaxation dispersion or NMRD profiles). 
This thesis contains two main parts: an ‘overarching statement’, which is meant to serve as an 
introduction to the assessable work, and a compilation of the research publications (at the 
end). The overarching statement is divided into five chapters and is written in a slightly 
unorthodox fashion to increase the readability and logical flow of material and avoid ‘future 
referencing’ to necessary concepts. The basic principles of NMR and relaxation are discussed 
in Chapter 2, along with the details of the experimental techniques used to measure T1, T2 and 
relaxivity. This is followed by a description of MRI theory, its practical implementation, and 
its various innate contrast generating mechanisms, in Chapter 3. To understand the theory 
behind the relaxation enhancement of MRI CAs, a summary of some relevant NMR 
relaxation mechanisms and the related quantum mechanical derivation is then presented in 
Chapter 4, a detailed description of which can be found in Paper IV. This chapter also 
contains details on the fast field cycling relaxometric techniques of obtaining NMRD profiles 
(Section 4.3). Finally, in Chapter 5, a short summary of the different projects that constitute 
this thesis is presented, followed by conclusions and directions for future research. 
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Chapter 2. Principles of NMR and Relaxation 
 
 
 
 
 
This chapter contains verbatim passages from: 
 Gupta, A.; Stait-Gardner, T.; Ghadirian, B.; Price, W. S., Fundamental Concepts for the 
Theory, Dynamics and Applications of MRI. In Theory Dynamics and Applications of 
Magnetic Resonance Imaging - I, Awojoyogbe, O. B., Ed. Science Publishing Group: 
New York, 2014; pp 3-33. Reproduced with permission from the Science Publishing 
Group. 
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2.1 Nuclear Spin and Magnetic Moment 
All atomic nuclei have four important properties: mass, electric charge, magnetism and spin. 
Mass and electric charge are responsible for the physical and chemical properties of matter 
whereas the latter two properties form the basis of NMR (and hence MRI). Magnetism 
implies that atomic nuclei can act as small bar magnets when placed in an external magnetic 
field. Spin is an intrinsic quantum mechanical property which is difficult to visualise, but 
simplistically can be described as the magnetic moment, μ, of an atomic nucleus spinning 
about its own axis. This is associated with an inherent angular momentum, called the spin 
angular momentum, I, which is related to μ by 
 μ I  (3) 
where the proportionality constant, γ, is the gyromagnetic ratio (rad s-1 T-1). Eq. (3) indicates 
that only the spins
*
 with I ≠ 0 possess a magnetic moment and are thus ‘NMR active’. Most 
elements have at least one NMR active isotope. Commonly used isotopes in NMR studies 
include 
13
C, 
15
N, 
17
O, and 
19
F, however MRI is mainly performed with 
1
H because of its high 
natural abundance (i.e., 99.9%), high NMR sensitivity and high concentration in molecules in 
the body (i.e., water, fat and other organic molecules).  
2.2 Larmor Precession and Net Magnetisation 
NMR involves the application of a strong static magnetic field, B0, to the spins. To 
understand how spins behave in the presence of B0, it is useful to discuss the following 
analogy. Imagine a bicycle wheel hung by one end of its axle as shown in Figure 7 (a). If the 
wheel is not spinning, it will simply fall down under the effect of gravity. But if the wheel is 
spinning, it will instead start revolving around the fixed end while rotating about its axle. 
This simultaneous rotating revolving motion is called precession. This is precisely how (the 
magnetic property of) a nuclear spin interacts with the external magnetic field. Instead of 
flipping towards the magnetic field, it starts precessing about it (Figure 7 (b)). The angular 
frequency of precession, ω0, is referred to as Larmor frequency (i.e., the resonance 
frequency) and its magnitude is dependent on the external magnetic field strength as  
 0 0.B   (4) 
                                                 
*
 In
 NMR jargon, atomic nuclei are often denoted as ‘nuclear spins’ or ‘spins’. 
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Figure 7: (a) A bicycle wheel spinning about its own axis will start precessing if hung by one end of its axle. (b) 
Similarly, when placed in an external magnetic field (B0), a nuclear spin starts precessing about the direction of 
B0 with the Larmor precessional frequency, ω0.  
 
A small digression: the magnetic field experienced by a nucleus is not necessarily exactly that 
of the externally applied magnetic field. The electron shells surrounding a nucleus ‘shield’ a 
nucleus from the magnetic field and thus the Larmor frequency is slightly changed by the 
local chemical environment (‘the chemical shift’). Thus, for example, the –OH proton of 
methanol will resonate at a slightly different frequency than that of the corresponding –CH3 
protons. Typically though these are extremely small perturbations to the resonance frequency 
with the values normally being within a few parts per million of 0.
48, 49
  
Of course, as is the case with the spinning bicycle wheel, the nuclear spin does try to align its 
magnetic moment with the external magnetic field to minimise the energy of magnetic 
interaction between them as given by 
 0.E   μ B  (5) 
However, in the case of protons, it turns out that the average thermal energy associated with 
the absolute temperature, kT (where k is the Boltzmann’s constant), is much higher than E. 
For example, using Eqs. (3) and (5), the difference in the energy of magnetic interaction of a 
proton between the two spin states (aligned and anti-aligned with external magnetic field) can 
be calculated to be 4.23×10
-26
 J at 1.5 T magnetic field strength (same as that of most clinical 
MRIs). Whereas, the thermal energy associated with the proton at physiological temperatures 
(37 °C or 310.15 K) is 4.28×10
-21
 J, about 10
5
 times larger than E. This implies that even in 
the presence of the magnetic field, the spins are mostly randomly oriented with only a small 
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preference towards the direction of the applied field. But since there are an extraordinary 
number of nuclei even in the smallest sample (e.g., a mg of tissue), this statistically tiny 
alignment can conduce to a net magnetisation, M0 (Figure 8), referred to as the thermal 
equilibrium value of the net magnetisation. 
 
 
Figure 8: A schematic representation of nuclear spins before (left) and after (right) the application of an external 
magnetic field, B0. In the absence of B0, the magnetic moments of nuclear spins are randomly oriented resulting 
in no net magnetisation. Whereas, in the presence of B0, there is a slight preference of magnetic moments to 
align with B0 resulting in a small net magnetisation, M0.  
 
2.3 Radiofrequency Pulse and Signal Detection 
To extract information from the sample, it is necessary to be able to detect the net 
magnetisation. Only the component of the net magnetisation that is oriented perpendicular to 
B0 (i.e., transverse magnetisation) is detectable. Thus, an NMR (or MRI) experiment begins 
by nutating M0 away from B0 using a perpendicular magnetic field, B1, oscillating at the 
Larmor frequency for a short time. Since the Larmor frequencies at most practical magnetic 
field strengths lie within the radio-frequency (rf) range (3 kHz – 300 GHz), this short burst of 
an oscillating perpendicular magnetic field is termed as a radio-frequency pulse (rf pulse). 
The resonance between the rf pulse and the Larmor frequency of the nuclei (i.e. ωrf = ω0) 
ensures that the net magnetisation receives a continuous push (actually a nutation) towards 
the transverse plane. The angle by which the net magnetisation is rotated (rotation angle) 
depends on the strength and duration of the rf pulse. It is common in NMR to name the rf 
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pulse based on the rotation angle. For example, an rf pulse which rotates the magnetisation by 
180° is called a π pulse or a 180° pulse. 
Since there are two precessions involved (one about B0 and one about B1) during the 
application of an rf pulse, it is much simpler to visualise this effect in a reference frame 
rotating at the frequency of the rf pulse
*
, otherwise known as the rotating frame of reference 
(RFR). In the RFR, at thermal equilibrium, the spins precessing about B0 will appear 
stationary and B0 can be ignored as its effect has already been accounted for in the rotation of 
the reference frame. Also, the rf pulse will appear static and the spins will appear as if only 
precessing about B1 at a frequency ωrf = γB1 (Figure 9). 
 
 
Figure 9: The effect of an rf pulse on the net magnetisation in the laboratory and rotating frame of references. In 
the laboratory frame of reference, the two simultaneous precessions about the external magnetic field, B0, and 
oscillating magnetic field B1 makes the overall motion of the net magnetisation appear as a spiral. This can be 
simplified by using a reference frame rotating at the frequency of the rf pulse (or Larmor frequency), called the 
rotating frame of reference (RFR). In RFR, the effect of B0 can be ignored and B1 appears stationary. Thus, the 
net magnetisation appears to be precessing about B1 only.  
 
After the rf pulse is turned off, the net magnetisation, now in the transverse plane, continues 
its usual precession about B0. This precessing magnetisation generates a changing magnetic 
field which induces an oscillating electric current via Faraday induction in a nearby receiver 
                                                 
*
 In many texts, RFR is arbitrarily chosen to be rotating at the Larmor frequency instead of the rf pulse 
frequency. Although in the present case it would not make a difference since they are both equal, in the quantum 
mechanical description of MRI it is more useful to describe ωrfr = ωrf to account for the very small difference 
between ωrf and ω0 at the resonance condition. 
  
18 
 
coil. The induced current is then amplified and digitised by an analogue-to-digital converter 
to give an NMR signal known as the free induction decay (FID). The FID is an exponentially 
decaying sinusoidal signal in the time domain. As can be seen from Figure 10, it is very hard 
to deduce the Larmor frequencies of nuclei in differing chemical environments (such as 
situated in or near different functional groups) with different resonance frequencies from the 
FID. To resolve this, the FID is Fourier transformed to the frequency domain (i.e., an NMR 
spectrum) in which each exponentially decaying signal is converted to a Lorentzian shaped 
peak. In an NMR spectrum, the Larmor frequencies can be easily identified by the 
corresponding peaks (Figure 10).
50, 51
  
 
  
Figure 10: Simulated free induction decays (left) and their NMR spectra (right) obtained by applying the 
Fourier transforms. The offset Larmor frequencies were set to (a) 30 Hz and (b) 30 and 50 Hz (a situation where 
either different nuclei are present or the same nuclei are present in two different environments). T2 was set to 2 s 
in both cases. Whilst it is hard to deduce the Larmor frequencies of the nuclei contributing to the FID signal 
(time domain), the frequencies can be easily identified by the corresponding peaks in the NMR spectrum 
(frequency domain). 
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2.4 Relaxation 
After the rf pulse, while the FID is being recorded, the net magnetisation returns to its 
equilibrium position by a process known as spin relaxation. This includes the reduction of the 
transverse magnetisation to zero (transverse relaxation) and the returning of the longitudinal 
magnetisation back to its equilibrium value (longitudinal relaxation).
52, 53
 The two processes 
are outlined in Figure 11 and briefly discussed below. Note that for the sake of discussion, B0 
is assumed to be oriented along the z-axis.  
 
Figure 11: A schematic representation of the relaxation process. The net magnetisation is along the direction of 
the applied magnetic field, B0, at equilibrium. The π/2 rf pulse rotates it to the x-y plane. Relaxation drives the 
transverse magnetisation to zero (transverse relaxation) and the longitudinal magnetisation to its equilibrium 
value (longitudinal relaxation). 
 
2.4.1 Longitudinal Relaxation 
Longitudinal relaxation is also known as spin-lattice relaxation or somewhat erroneously, T1 
relaxation. At the microscopic scale, it refers to the movement of spin populations back to 
their Boltzmann distribution values.
53
 The return of the z-component of the net magnetisation, 
Mz, to its equilibrium value, M0, is usually a first-order process given by  
 z 0z
1
( )M MdM
dt T

   (6) 
where T1 is the spin-lattice relaxation time constant.
54
 After one T1, Mz returns to 63% of its 
equilibrium value and by 5T1, Mz has returned to almost 100% of its equilibrium value. 
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2.4.1.1 Longitudinal Relaxation Time Measurement 
Various methods
55, 56
 have been proposed to measure T1 but the inversion recovery method is 
the method of choice.
57
 The inversion recovery pulse sequence consists of a π pulse followed 
by a π/2 pulse after an interval τ as shown in Figure 12. 
 
 
Figure 12: The inversion recovery pulse sequence. The sequence is repeated for various values of τ to obtain a 
profile of the recovery of the longitudinal magnetisation as shown in Figure 13.  
 
Each repetition of the pulse sequence is separated by a recycle delay of ≥ 5T1. The πx pulse 
inverts the net magnetisation from z to –z direction. As the magnetisation relaxes back to 
equilibrium during the τ delay, a π/2x pulse is applied to rotate the magnetisation into the x-y 
plane for signal detection as shown in Figure 13. The pulse sequence is repeated with 
different values of the relaxation interval τ to obtain a profile of the recovery of the 
longitudinal magnetisation. From Eq. (6) and the form of the pulse sequence it can be shown 
that the intensity of the observed longitudinal magnetisation is given by 
53
 
 1
/
0( ) (1 2 ).
T
M M e
    (7) 
Eq. (7) is then regressed onto the magnetisation recovery profile to obtain an estimate of T1.  
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Figure 13: A schematic representation of the inversion recovery method of measuring T1. Net magnetisation is 
inverted by a π pulse. As it relaxes back to its thermal equilibrium, a π/2 pulse is applied at varying intervals (τi) 
to obtain signals with varying intensities. 
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2.4.2 Transverse Relaxation  
Transverse relaxation, also known as spin-spin relaxation or, somewhat erroneously, T2 
relaxation corresponds to the loss of transverse magnetisation. This results from the loss of 
coherences amongst the spins precessing in the transverse plane. The decay of the x and y 
components of magnetisation, Mx and My, is also usually a first order process given by 
 
y yx x
2 2
 or 
dM MdM M
dt T dt T
     (8) 
where T2 is the spin-spin relaxation time constant.
54
  
2.4.2.1 Transverse Relaxation Time Measurement 
In principle, T2 can be estimated by measuring the line-width at half height of the signal, but 
this is rarely reliable. The main reason being the non-uniformities in the external magnetic 
field arising from imperfect ‘shimming’ or magnetic susceptibility inhomogeneities in the 
sample also contribute to the line-width (inhomogeneous broadening). Consequently, the 
measured line-width is given by:
58
 
 
1/2 *
2
1
      
T


   (9) 
where 
 
*
2 2 2 inhomogenous.T T T   (10) 
Therefore, to measure T2 accurately, it is necessary to suppress the inhomogeneous 
broadening which is achieved by using the ‘spin-echo’ technique. The simplest ‘spin-echo’ 
pulse sequence was first proposed by Hahn in 1950, hence known as the Hahn ‘spin-echo’ 
pulse sequence (π/2 – τ/2 – π/2 – τ/2 – echo).59 This sequence was modified a few years later 
by Carr and Purcell to replace the second π/2 pulse with a π pulse.60 In the modified Hahn 
‘spin-echo’ pulse sequence, the net magnetisation is first excited by a π/2 pulse to precess in 
the x-y plane. Due to magnetic field inhomogeneities and, in the case of multiple resonances, 
different chemical shifts, the magnetisation components start precessing at slightly different 
rates. A π pulse is applied after time τ/2 to invert the magnetisation and hence, refocus the 
components. An echo signal is finally acquired after waiting another τ/2 time interval (Figure 
14). This sequence is still prone to artefacts arising from diffusion (i.e. where spins move to 
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different regions of the sample and thus different static fields due to self-diffusion), to 
overcome that and to reduce the sensitivity of the experiment to small miscalibration of the 
pulse durations, Carr, Purcell, Meiboom and Gill further modified the sequence to repeat the 
echo cycles multiple times and by changing the phase of π pulses from x to y.56 The most 
common method to measure T2 accurately is thus known as the CPMG (Carr-Purcell-
Meiboom-Gill) pulse sequence (Figure 15). The number of echo cycles is varied in an 
arrayed fashion and the intensities of the echo signals are plotted against τ to get an 
exponential decay curve. Regression of  
 2
( / )
0
T
M M e
  (11) 
onto the magnetisation decay curve allows T2 to be determined.
61
 
 
 
Figure 14: Modified Hahn ‘spin-echo’ pulse sequence. The net magnetisation is excited by applying a π/2 
pulse. The magnetisation components start precessing in the x-y plane at slightly different rates due to the non-
uniform magnetic field. A π pulse is thus applied after time τ/2 to refocus the components and hence an echo is 
acquired after waiting for the same time τ/2.   
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Figure 15: The Carr-Purcell-Meiboom-Gill (CPMG) pulse sequence for determining T2. The echo time is 
altered by varying n. 
 
2.4.3 Relaxivity Measurements for MRI Contrast Agents  
As discussed in Chapter 1, the relaxivity of an MRI CA can be determined by measuring the 
relaxation rate enhancement caused by the addition of the CA, normalised to its concentration 
(Eq. (1)). However, instead of measuring the relaxation rates in the presence and absence of a 
paramagnetic CA (to determine the exact change), it is usual to measure the Ti of three or 
more dilutions of a particular CA. In this way, relaxivity is equal to the slope of the 1/Ti 
versus [CA], as can be seen by rearranging Eq. (1) 
 i
i i,d
1 1
[CA]         1,2.r i
T T
     (12) 
Here, 1/Ti,d refers to the diamagnetic relaxation rate of the water protons i.e., in the absence 
of the MRI CA. As an example, the relaxivities of Magnevist (Figure 2) was determined to be 
r1 = 3.96 ± 0.02 and r2 = 5.13 ± 0.07 mM
-1
 s
-1
 at 9.40 T and 25 °C (Figure 16).  
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Figure 16: Plots of the 
1
H longitudinal () and transverse () relaxation rates versus Gd(III) concentration for 
Magnevist at 9.40 T and 25 °C. r1 and r2 can be determined from the slopes of the linear fits to be equal to 3.96 
and 5.13 mM
-1
 s
-1
.  
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Chapter 3. Fundamentals of MRI and MRI 
Contrast 
 
 
 
 
This chapter contains verbatim passages from: 
 Gupta, A.; Stait-Gardner, T.; Ghadirian, B.; Price, W. S., Fundamental Concepts for the 
Theory, Dynamics and Applications of MRI. In Theory Dynamics and Applications of 
Magnetic Resonance Imaging - I, Awojoyogbe, O. B., Ed. Science Publishing Group: 
New York, 2014; pp 3-33. Reproduced with permission from the Science Publishing 
Group. 
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3.1 Gradients - One Dimensional Imaging 
Thus far, it has been discussed how an NMR spectrum can be obtained from a sample placed 
in a homogenous magnetic field. The next step is to consider how NMR can be used to obtain 
an image of the sample. Recall that the primary objective of imaging is normally to obtain 
information on the nuclear spin density, ρ, at each point in the sample. To do so, it is 
necessary to spatially vary the behaviour of the nuclear spins so that spins at different 
positions give different signals. This can easily be achieved in NMR by varying the external 
magnetic field in some direction by applying a magnetic gradient, G. This spatially varying 
magnetic field results in otherwise identical spins at different positions having different 
Larmor frequencies. Thus, in the presence of the magnetic gradient, the Larmor frequency 
becomes a function of position, r, as given by 
 0( )    r B G r  (13) 
with the detected signal having the following form 
 ( ) ( )e d .i tS t   
G r
r r   (14) 
For example, an hour-glass filled with water placed in a magnetic field gradient will result in 
an NMR spectrum which is the projection of the distribution of spins onto the gradient 
direction (Figure 17). The amplitude of the signal at each frequency will be proportional to 
the number of spins in that frequency region, i.e., (r).9, 62  
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Figure 17: An example of the use of a magnetic gradient to obtain a one dimensional image of an hour-glass 
filled with water. The external magnetic field and the gradient are applied in z-direction. Due to the applied 
gradient, the Larmor frequency becomes a function of the z-position and thus the NMR spectrum represents the 
distribution of the Larmor frequencies with the signal-amplitude at each frequency proportional to the number of 
spins in that frequency region. Thus, the image is a 1D projection of  along the direction of the gradient. 
 
3.2 Three Dimensional Imaging - Spatial Encoding 
Although the previous example is useful for understanding the effect of applying a magnetic 
gradient, it is important to consider that for medical imaging, ρ is almost always a three 
dimensional (3D) quantity. And by extension of the previous example, the acquisition of a 3D 
image entails the application of three orthogonal gradients. How these three gradients are 
utilised to impart spatial dependence to the nuclear spin density, a process known as spatial 
encoding, is discussed in the following sections.    
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3.2.1 Slice Selection 
The first gradient is used to select a two dimensional (2D) region of interest from the sample, 
a process known as slice selection. This is obtained by applying a well-defined gradient 
known as the slice gradient along (say) the z-axis throughout the sample in conjunction with a 
frequency selective rf pulse.
63
 As depicted in Figure 18a, the slice gradient, Gz, varies the 
precession frequency of the spins linearly along the z-axis while the frequency selective rf 
pulse affects only those spins within the frequency range of excitation. The result is that only 
a limited part of the sample (the slice) is excited. Consequently, only the magnetisation 
contained within the slice is rotated into the transverse plane and contributes to the NMR 
signal. The slice thickness, ∆z, is dependent on the strength of the applied gradient and the 
bandwidth of the frequencies incorporated into the rf pulse, Δωrf,  
 rf
z
.z
G



   (15) 
It should be noted that regardless of the physical thickness, the selected slice is considered as 
a 2D object which can be manipulated to give a 1D or 2D image only. In other words, the 
selected slice is always considered one voxel (volume element or a ‘3D pixel’) thick and all 
the information from ∆z is averaged to one signal. To get a 3D image, multiple slices can be 
selected, imaged and stacked on each other. The position of the slice depends on the 
resonance frequency of the rf pulse with respect to the Larmor frequency,  
 rf 0
z
.z
G
 


  (16) 
The two commonly used slice selection schemes are shown in Figure 18b and c. The 
magnetisation components within the slice are dephased immediately after the application of 
the rf pulse which results in the destructive interference of the signals originating from the 
different positions of the slice.
9
 Thus, a negative gradient is applied for a short period of time 
immediately after the use of the rf pulse to refocus the magnetisation. Alternatively, 
depending on the pulse sequence, a π pulse can be used, in which case, the magnetisation 
refocusses automatically. 
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Figure 18: (a) A schematic representation of the slice selection process in MRI. Before the application of a 
magnetic gradient, all the spins are precessing at the same frequency, ω0. In the presence of a gradient along the 
direction of B0 (i.e. z- axis), the spins at different z-positions start precessing at slightly different frequencies. If 
a frequency selective rf pulse is applied, only the corresponding spins are rotated into the transverse plane, thus 
a ‘slice’ is selected. The two commonly used pulse sequences are shown in (b) and (c). A short negative gradient 
is applied to refocus the magnetisation that had been dephased after the application of the rf pulse. Alternatively, 
a π pulse can be used. 
 
The other two gradients are used to localise the signal within the selected slice so that 
eventually every voxel gives a different NMR signal. The two common parameters that can 
be modulated to provide spatial dependence are phase and frequency as discussed in the next 
section.
64
 For simplicity, it has been assumed that the selected slice has nine voxels and every 
voxel contains only one spin. 
 
3.2.2 Phase Encoding 
After the slice has been selected, all the spins within the slice are in the transverse plane. If a 
gradient is applied along (say) the y-axis for a fixed time t before acquiring the signal, the 
phase, φ, will become a function of position y as given by 
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 0 φ
0
( ) ( )
t
y B G y dt    (17) 
where Gφ is the phase gradient. This is because in the presence of the phase gradient, the 
nuclear spins along the y-axis will start precessing at slightly different frequencies and thus 
will have different phases at any instant. So when the gradient is stopped, although the spins 
retain their original precession frequency, the phase differences amongst them still remain the 
same. This process is known as phase encoding and is depicted in Figure 19a. Note that the 
amplitude of the signal recorded after phase encoding is inversely proportional to the strength 
of the applied phase gradient. The reason for this is that a stronger phase gradient results in a 
larger phase difference between the neighbouring spins and although this helps to resolve 
them better, the total signal from the spins is dephased resulting in lower amplitude.
65
 
Rapid switching of the gradients generates eddy currents in the nearby conducting materials, 
creating a secondary source of gradients. This results in a distorted FID and hence the 
resulting image contains artefacts. A common solution for this is to use an echo sequence to 
allow the field distortions to dissipate before signal acquisition begins. The two common 
types of echo sequences are: ‘spin-echo’ sequences and ‘gradient-echo’ sequences. In the 
‘gradient-echo’ sequence, only the gradient induced phase dispersions are refocussed in 
contrast to the ‘spin-echo’ sequence, in which phase dispersions due to the magnetic 
inhomogeneities and chemical shifts are refocussed as well.
62, 66, 67
 The phase encoding in the 
‘spin-echo’ and ‘gradient-echo’ pulse sequences are shown in Figure 19b and c.  
  
33 
 
 
Figure 19: (a) An illustration of the phase encoding process in MRI. On the application of the phase gradient to 
the selected slice along the y-axis, the spins start precessing at different frequencies and, therefore, have 
different phases at any instant. After the gradient is stopped, although the spins start precessing at the same 
original frequency, the phase differences amongst them are retained as a function of position. (b) and (c) Phase 
encoding in the ‘spin-echo’ and ‘gradient-echo’ pulse sequences, respectively. The phase gradient can be 
applied either before or after the π pulse. 
 
3.2.3 Frequency Encoding 
Once the slice is selected and phase encoded, only one more direction needs to be resolved to 
get different signals from every voxel. The final gradient is applied along the x-axis while the 
signal is being recorded. This has the same effect as was explained in the one dimensional 
imaging example above i.e. the Larmor frequencies of the voxels along the x-axis become 
spatially dependent and Eq. (13) can be written as 
 0 f( ) ( )x B G x     (18) 
where Gf is the frequency gradient, commonly known as the ‘read’ gradient.
68
 This process is 
known as frequency encoding and is depicted in Figure 20a. It is clear that at the end of phase 
and frequency encoding, all the voxels in the selected slice are different from each other 
either in their phase or frequency and will, therefore, give different signals.  
  
34 
 
 
Figure 20: (a) A pictorial representation of the frequency encoding process in MRI. After phase encoding along 
the y-axis, the signal is recorded in the presence of the frequency gradient along the x-axis. (b) ‘spin-echo’ 
scheme in which the sign of the magnetic gradient is effectively negated by the π pulse. In this scheme, phase 
dispersion due to magnetic inhomogeneities and chemical shifts and gradient-induced dispersions are 
refocussed. (c) ‘gradient-echo’ scheme in which the magnetic gradients are antiphase. In this scheme, only 
gradient-induced dispersions are refocussed. 
 
Putting it all together, complete basic ‘spin-echo’ and ‘gradient-echo’ MRI pulse sequences 
are illustrated in Figure 21 and Figure 22. TE (echo time) is the time between the application 
of the rf pulse and the acquisition of the signal and TR (repetition time) is the time between 
the two pulse sequences. It should be noted that although in the above discussion, the slice, 
phase and frequency gradients have been assumed to be along the z-, y- and x-axes, 
respectively, in an MRI experiment, they can be applied along any three orthogonal 
directions. 
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Figure 21: A basic ‘spin-echo’ MRI pulse sequence. TR is the repetition time and TE is the time between the 
application of the rf pulse and the acquisition of the signal, also known as echo time. The phase gradient is 
drawn with equally spaced horizontal lines to indicate that its magnitude is stepped up regularly when the 
sequence is repeated multiple times.  
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Figure 22: A basic 'gradient-echo' MRI pulse sequence. 
 
It should be noted that where one frequency gradient is enough to resolve the voxels along 
the x-axis, the entire process from slice selection to signal detection needs to be repeated 
multiple times with different phase gradients (ranging from relative maximum negative to 
relative maximum positive) to completely resolve the voxels along the y-axis. The reason 
behind this is will become apparent in the following sections.  
 
3.3 Raw Data Matrix and k-Space 
Since a number of scans are needed to get enough information on one slice that a detailed 2D 
MRI image can be reconstructed from it, an efficient way of storing the raw data is essential. 
An obvious choice is to digitise the recorded echo signal by sampling the amplitudes as a 
function of time. This digital form of an echo is stored as a row of complex numbers. The 
same process is repeated for the echoes obtained with different phase gradients and these 
rows of complex numbers are stacked on top of each other to give a (complex) raw data 
matrix with the bottommost row representing the maximum negative phase gradient and the 
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topmost row maximum positive (Figure 23). It is usual to display the real and imaginary parts 
of the complex raw data matrix as separate matrices and convert the numbers to the greyscale 
values.  
The raw data matrix has the dimensions of Nφ× Nf where Nφ is the number of phase gradients 
used and Nf is the number of data points recorded in the frequency encoding direction. The 
maximum signal is present in the centre of the raw data matrix because the phase gradient is 
the weakest there. The central region is mainly responsible for the image contrast. The outer 
regions of the raw data matrix have signals with low amplitudes due to strong phase 
gradients. These regions contain very little information about the image contrast and mainly 
contribute to the edge definition of the image.
63
  
 
Figure 23: An illustration of how the raw data is stored in MRI. The echoes are digitised by sampling their 
amplitudes as a function of time to give rows of complex numbers. The real (or imaginary) parts of the complex 
numbers can be displayed as greyscale values and stacked on top of each other to give a raw data matrix with 
the bottommost row representing the maximum negative phase gradient and the topmost row maximum positive.  
 
In MRI, the raw data matrix is often described in terms of wave numbers. A wave number, k, 
is the number of wavelengths per 2π units of distance i.e. k = 2π/λ (rad/m), where λ is the 
wavelength. Analogous to frequency which is the number of oscillation per unit time, k is 
also called the spatial frequency. The spatial frequency is proportional to the gradient strength 
and the duration of the gradient. This is because a higher gradient strength gives a greater 
frequency differential and a longer duration gradient gives a greater phase differential which 
results in shorter wavelengths and correspondingly larger k-values (Figure 24).  
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Figure 24: The effect of the gradient strength and/or duration on the wave number, k. The external magnetic 
field is assumed to be applied along the z-axis and the spins are shown after the application of a π/2 pulse (i.e. 
the spins are in the transverse plane). When there is no gradient, all the spins are rotating at the same frequency 
and therefore, in the rotating frame of reference rotating at ω0, the spins appear stationary with no phase 
difference. In the presence of a gradient, Gy, the spins start precessing with slightly different frequencies and 
hence a phase difference is induced, winding them into a helix. As the gradient strength and/or duration, t, 
increases, the pitch of a helix becomes smaller resulting in a shorter wavelength and correspondingly a higher k 
value.  
 
Thus, the k-values along the phase and frequency encoding axes can be written as   
 
y φ
x f
and
,
k G t
k G t




  (19) 
respectively. Also, after making the adjustments to Eq. (14), the acquired signal (echo) can be 
written as a function of k, 
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Combining these equations, the total signal from the selected slice can be written as  
 x y
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x y( , ) ( )e .
i k x k y
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
     (21) 
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Consequently, the raw data matrix can be edited to replace ‘time’ with ‘kx’ along the x-axis 
and ‘Gφ’ with ‘ky’ along the y-axis. In other words, each point along the frequency encoding 
axis now corresponds to the kx value and along the phase encoding axis to the ky value 
(Figure 25). This description of the raw data matrix is known as the k-space formalism; and 
the raw data matrix itself is in k-space.  
 
 
Figure 25: Two descriptions of the raw data storage. Although both the matrices contain the same data, it is 
convenient to describe the signal as a function of the spatial frequency, k, as it makes it easier to describe 
different methods of acquiring data using various MRI pulse sequences.  
 
3.4 Image Reconstruction 
Recalling that an MRI image is essentially the nuclear spin density in ‘real space’ (i.e. ρ(x, y)) 
and realising from Eq. (21) that the signal in k-space is in fact an inverse Fourier transform of 
the nuclear spin density in ‘real space’, it is evident that an MRI image of the selected slice 
can be reconstructed by the 2D Fourier transform of the signal in k-space (Figure 26) as 
given by  
 x y
2 ( )
x y x y( ) ( , )e .
i k x k y
x, y S k k dk dk


 
     (22) 
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Figure 26: An MRI image can be reconstructed by applying a 2D Fourier transform to the k-space data. Note 
that only the magnitude of the k-space data is shown here (as the k-space data from MRI is inherently complex). 
 
3.5 MRI Contrast 
As discussed in Chapter 1, image contrast between different tissue types is of utmost 
importance for every imaging modality. There are many endogenous sources of contrast in 
MRI such as spin density, ρ, nuclear spin relaxation times, T1 and T2,
69
 chemical shift,
70, 71
 
magnetic susceptibility,
72, 73
 and diffusion.
74
 Although an MRI image depends on all the 
contrast factors to some extent, it is possible to experimentally enhance the contrast with 
respect to a particular factor, a process known as ‘weighting’, by adjusting parameters such as 
TR and TE (see Figure 21 and Figure 22). Three main contrast generating mechanisms: ρ0, T1 
and T2 (or T2
*
) are discussed in the following sections along with the techniques to weight 
image contrast on a particular source. 
For reference, the contrast between tissues A and B, CAB, for a gradient-echo experiment 
(Figure 22) can be written as the difference between the signals of two tissues, as given by  
 
A *A B *B
R 1 E 2 R 1 E 2/ / / /A B
AB A B (1 ) (1 ) .
T T T T T T T T
C S S e e e e           (23) 
Note that Eq. (23) shows that signal intensity increases with decreasing T1 and decreases with 
decreasing T2.
8, 75
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3.5.1 T1-Weighting 
The T1 values of water protons differ between the different types of normal soft tissues, thus 
making T1-weighting a powerful contrast method for their delineation. To get an effective T1-
weighting, T2
*
 effects have to be minimised, which, from Eq. (23), can be achieved by 
reducing TE such that TE << T2
*A,B
. In this case, the contrast will be 
 
A B
R 1 R 1/ /A B
AB (1 ) (1 )
T T T T
C e e       (24) 
which can be rearranged to give 
 
A B
R 1 R 1/ /A B A B
AB ( ) ( ).
T T T T
C e e         (25) 
To maximise T1-weighting, a short TR should be used to prevent any relaxation losses 
between the scans and thus enhance the differences in the T1 values of different tissues.
75
 
However, an optimum TR can also be calculated from Eq. (25) by differentiating CAB with 
respect to TR and setting it to zero. This results in the following expression 
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. (26) 
3.5.2 T2/ T2
*
-Weighting 
Most diseased tissues have an elevated T2 (or T2
*
), which is why T2-weighting is a commonly 
used technique in clinical MRI.
8
 To get an effective T2-weighting, it is important to minimise 
the T1 effects. From Eq. (23), this can be achieved by setting a very long TR (TR >>T1) so that 
R 1/T Te

approaches zero. In this way, the contrast will then approach 
 
*A *B
E 2 E 2/ /A B
AB
T T T T
C e e    . (27) 
Since, the contrast is only dependent on TE, optimal T2-weighted contrast can be obtained by 
maximising CAB relative to TE.
75
 The optimal TE can be calculated to be  
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3.5.3 Spin Density Weighting 
Spin density contrast provides image contrast on the basis of the number of spins (e.g. water 
protons) present in a voxel. Since MZ of each voxel is composed of the individual spins 
within that voxel, varying spin density across the tissues results in different MZ and thus 
provides contrast to the images. For example, in 
1
H MRI, blood will appear brighter than 
muscles which in turn will appear much brighter than bones. To maximise spin density 
contrast, T1 and T2
*
 contrasts must be minimised which can be achieved by using a very long 
TR and a very short TE, respectively.
75
 After minimising the T1 and T2
*
 effects, the contrast 
(from Eq. (23)) is given by 
 
A B
ABC    . (29) 
Note that spin density contrast is inherent in the tissues. That is, although the contrast due to 
T1 and T2
*
 can be minimised, spin density contrast cannot be altered by adjusting any 
experimental parameters.
75
 
  
  
43 
 
 
 
 
 
 
 
 
 
 
Chapter 4. Relaxation Theory for Paramagnetic 
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4.1 Relaxation Mechanisms 
Recall from Chapter 2 that the equilibrium macroscopic magnetisation, M0, is a result of a 
slight statistical preference of numerous magnetic moments, μi, (of nuclei) towards the 
direction of the applied magnetic field, B0, and that the magnetic moments continually 
precess about B0 at the Larmor frequency ω0. The equilibrium magnetisation can be 
perturbed (i.e., deviated from B0) by applying an rf pulse. In this way, relaxation is defined as 
the realignment of the perturbed magnetisation with B0. But for this to occur, some innate 
oscillating magnetic field (resembling an rf pulse) must be present to rotate the magnetic 
moments back to their equilibrium positions. (Note that the individual magnetic moments 
behave exactly the same way as the bulk magnetisation during the rf pulse and the period of 
free precession
52
). In fact, there are many sources of such magnetic fields in an NMR system 
such as the magnetic fields generated by neighbouring nuclei and electrons. Since, the 
neighbouring nuclei and electrons are all reorientating at random rates (due to thermal 
motion); the magnetic fields generated by them will also be randomly oscillating. Out of 
these, only those oscillating at or very near to the Larmor frequency (or 2×Larmor frequency) 
can cause the relaxation, just as was the case for an rf pulse. Although these randomly 
oscillating magnetic fields resemble an rf pulse in the essence of their effect on magnetic 
moments, both are very different. The rf pulse is uniform and affects all the nuclei the same 
way, whereas the magnetic fields responsible for relaxation are random (both in magnitude 
and direction) and thus their effect is highly localised (i.e., different nuclei will experience 
different magnetic fields). As a result, these fields are often referred to as ‘local fields’.  
In an analogous quantum mechanical description, the spins possess some magnetic energy as 
a result of the interaction between μi and B0. At equilibrium, this magnetic energy is the 
lowest due to the slightly (statistically) higher number of spins in the low energy state (i.e., μi 
aligned with B0). When the equilibrium is disturbed by applying an rf pulse at the Larmor 
frequency, the spins in the lower energy levels absorb (transition) energy from the 
surroundings (thermal motion of the molecules) resulting in a net increase in the magnetic 
energy of the spins. To relax, the spins lose the ‘extra’ magnetic energy back to the 
surroundings. This flow of energy between the spins and surroundings is facilitated by the 
local fields.
48, 52, 53, 76-78
  
In NMR relaxation, the different sources of fluctuating local fields are called relaxation 
mechanisms. Some of the common relaxation mechanisms are the dipole-dipole (DD, direct 
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‘through space’ interaction with neighbouring nuclei), quadrupolar (QR, interaction with 
neighbouring spin > ½ nuclei), scalar (SC, indirect interaction with neighbouring nuclear 
spins through bonded electrons), chemical shift anisotropy (CSA, interaction with anisotropic 
local electronic environment) and spin rotation (SR, interaction with magnetic fields 
generated by the rotational motion of the molecules).
53, 76, 79, 80
 Relaxation theory mainly 
comprises the derivations of the mathematical expressions for the time dependence of the 
longitudinal and transverse relaxation for every (important) relaxation mechanism in a 
particular system. In the case of paramagnetic MRI CAs, the DD and SC mechanisms are the 
most important relaxation mechanisms. A comprehensive derivation of the relaxation theory 
for the DD and SC relaxation mechanisms is given in Paper IV. In the following two sections, 
a brief description of these mechanisms along with the final (derived) expressions for T1 and 
T2 is presented.  
4.1.1 Dipole-Dipole Relaxation  
In the DD relaxation mechanism, the source of the local fields is the magnetic fields 
generated by the neighbouring spins with magnetic moments, both in the same molecule 
(intramolecular) and in neighbouring molecules (intermolecular).
48
 For example, in the case 
of an isolated pair of two spin-½ nuclei: 1 and 2, the net magnetic field experienced by, say, 
spin 1 would be the sum of the external magnetic field and the local field generated by spin 2 
at the site of spin 1 and vice-versa. Such local fields depend on the following parameters: (1) 
gyromagnetic ratios of the two spins as the higher gyromagnetic ratio means a higher 
magnetic moment which in turn means a larger local magnetic field generated by the spin, (2) 
the distance between the spins as larger distance would imply a weaker effect of the local 
field on the spin experiencing it and (3) the orientation of the vector joining the two spins 
relative to the external magnetic field. The contribution of the DD relaxation mechanism to 
T1 and T2 is given by (from Eqs. 197 and 215 in Paper IV). 
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where μ0 is the permittivity of vacuum, γ1 and γ2 and ω1 and ω2 are the gyromagnetic ratios 
and Larmor frequencies of spin 1 and 2, respectively, r is the distance between the two spins 
and τc is the correlation time. Since, in the case of paramagnetic MRI CAs, spin 1 is nuclear 
spin (labelled I) of the coordinated solvent nuclei (usually water protons) and spin 2 is the 
electron spin (labelled S) of the paramagnetic metal ion (see Figure 3), which implies that γ1 
= γI, γ2 = γs = g μB (where g is the electronic g factor, μB is the Bohr magneton),
61
 ω1 = ωI, ω2 
= ωs, and ωs ≫ ωI (therefore, (ωI + ωs)
2
 ≅ (ωI – ωs)
2
 ≅ ωs
2
), Eqs. (30) and (31) can be written 
as 
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The correlation time is given by 
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where, as discussed in Chapter 1, τm is the water residency time (reciprocal of the solvent 
exchange rate, kex), τR is the reorientational correlation time of the molecule, and Tie is the 
electronic relaxation time.
11, 81
 For paramagnetic complexes, electronic relaxation is 
explained in terms of zero-field splitting (ZFS) interaction 
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where ∆2 is the mean squared fluctuation and τv is the correlation time for the modulation of 
the ZFS interaction.
58
 
4.1.2 Scalar Relaxation  
Apart from the ‘through space’ dipole-dipole magnetic interactions, the two spins can also 
interact with each other indirectly through bonded electrons between them. This type of 
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interaction is called scalar (SC) or indirect dipole-dipole coupling (also called J-coupling or 
Fermi contact interaction). In the SC relaxation mechanism, there are two main sources of 
modulation: one due to chemical exchange between the spins and other due to the coupling 
with a fast relaxing spin (such as an electron spin). The contribution of SC relaxation to T1 
and T2 is given by (from Eqs. 228 and 230 in Paper IV) 
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where πJ12 is the spin-spin coupling constant and τsc is the correlation time. As before, for 
MRI CAs, the above equations take the following form 
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where A/ħ is the electron-nuclear hyperfine coupling constant (ħ = h/2π) and τsc is given by 
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4.2 Paramagnetic Relaxation Enhancement 
Paramagnetic relaxation enhancement refers to the effect of the addition of the paramagnetic 
MRI CAs on the relaxation rates of the solvent nuclei. The observed relaxation rate after the 
addition of a paramagnetic CA is given by 
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where (1/T)d is the diamagnetic contribution to the observed relaxation rate, i.e., the 
relaxation rate of water protons (or other solvent nuclei) in the absence of the paramagnetic 
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CA and (1/T)p is the relaxation rate due to the paramagnetic CA. The paramagnetic relaxation 
is dependent on the concentration of the CA and can be divided into three components: inner 
sphere (IS), second sphere (SS) and outer sphere relaxation (OS),
82
 as shown in Figure 27 
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These are briefly discussed below. 
 
 
Figure 27: A schematic representation of a Gd-based contrast agent in solution. Gd enhances the relaxation rate 
of the solvent nuclei directly coordinated to it (inner sphere relaxation), hydrogen bonded to it (second sphere 
relaxation) and diffusing past it (outer sphere relaxation).  
 
4.2.1 Inner Sphere Relaxation 
IS relaxation refers to the relaxation enhancement of the solvent nuclei directly coordinated 
to the metal ion (Figure 27).
83
 For dilute paramagnetic solutions, Swift and Connick
84
 and 
Luz and Meiboom
85
 derived the following equations for the IS relaxation rates 
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Here, Pm is the mole fraction of bound solvent nuclei, q is the number of bound nuclei per 
metal ion (hydration number), ∆ωm is the chemical shift and Tim is the relaxation rate of the 
coordinated solvent nuclei (in the inner sphere). If the solvent is water, Tim mainly depends 
on the DD and SC relaxation mechanisms (Eqs. (32) – (41)), as given by 
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In the case of Gd, ∆ωm can be neglected at most fields,
86
 thus Eq. (45) becomes 
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4.2.2 Second and Outer Sphere Relaxation 
In SS relaxation, the solvent nuclei in the second coordination sphere (hydrogen-bonded to 
the CA) relax via dipole-dipole interactions (Figure 27). SS relaxation can also be described 
by Eqs. (44) – (47), however, only the Ti
DD
 term applies to SS relaxation in Eq. (46).
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Although there is some literature
88
 supporting its significance, the contribution of SS 
relaxation is usually assumed to be negligible. 
OS relaxation refers to the relaxation enhancement due to the solvent nuclei diffusing past the 
paramagnetic CA (Figure 27). As shown by Hwang and Freed,
89, 90
 the OS relaxation rates 
are given by 
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where d is the distance of closest approach between the solvent nuclei and the paramagnetic 
complex, NA is Avogadro’s number and D is the translational diffusion coefficient. 
 
4.3  Nuclear Magnetic Relaxation Dispersion 
Nuclear spin relaxation is dependent on a number of experimental parameters such as 
temperature, pressure and magnetic field strength. Parameters such as temperature and 
pressure affect the molecular reorientation (τR) and water exchange (τm) whereas magnetic 
field dependence is evident in Eqs. (30) – (50) (particularly in spectral density functions, as 
discussed in Paper IV). The usual approach to understand the various interaction mechanisms 
and experimentally determine the relaxation parameters of a given system is to measure its 
relaxation rates as a function of temperature, pressure or magnetic field, and then fit 
appropriate theoretical models to the experimental data. However, variation in 
thermodynamic parameters often leads to undesirable changes in the physical or chemical 
state of the sample. Changing magnetic field, on the other hand, does not usually influence 
the chemistry of the sample and therefore provides a valuable means of exploring various 
relaxation processes.  
The measurement of relaxation rates as a function of the magnetic field strength (or Larmor 
frequencies) is called relaxometry. A logarithmic plot of the (Larmor) frequency dependence 
of 1/T1, in particular, is termed the nuclear magnetic relaxation dispersion (NMRD) profile 
(An example of an NMRD profile is given in Paper III.) NMRD profiles can be obtained by 
measuring T1 on various standard NMR spectrometers operating at different magnetic field 
strengths. However, this is time consuming, expensive, and only a few data points are 
possible. Moreover, most commercially available NMR spectrometers operate within the 
range of 20 – 900 MHz (1H Larmor frequencies), whereas the solutions of paramagnetic MRI 
CAs often show interesting features at low magnetic fields (< 1 MHz). This led to the 
development of a new relaxometric technique, known as fast field cycling (FFC) 
relaxometry.
91, 92
 The basic principles of the FFC method are discussed below. 
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4.3.1 Fast Field Cycling Relaxometry 
There are two main FFC techniques that are used to measure T1: prepolarised and 
nonpolarised. In prepolarised FFC relaxometry (Figure 28a), a polarisation magnetic field, 
Bp, is applied for a long time (~5T1 at that field) to polarise the nuclear spins of the sample. 
The magnetic field is then rapidly switched to the relaxation field, Br, at which the relaxation 
time is to be determined. The switching time for the fields must be much shorter than T1 to 
avoid any relaxation losses of the magnetisation. The magnetisation then relaxes to a new 
equilibrium value at Br. After a relaxation interval τ, a π/2 rf pulse is finally applied to detect 
the remaining magnetisation in the form of an FID. To avoid experimental complications 
(such as tuning and matching the probe at every relaxation field), the FID is also recorded at 
the same field, called the detection field, Bd. 
At high relaxation fields, where Br approaches Bp, the change in the equilibrium 
magnetisations becomes too small to accurately determine T1. In this case, the polarisation 
field is omitted and the nonpolarised scheme (Figure 28b) is used instead. In the nonpolarised 
scheme, the build-up of the magnetisation, after switching the magnetic field to Br, is 
observed as a function of τ.93, 94 
Therefore, in essence, the difference between the FFC relaxometric methods, described 
above, and the conventional methods of measuring the relaxation times, discussed in Section 
2.4, is the process of generating the non-equilibrium state. In the conventional methods, the 
non-equilibrium state is created by the disturbing the spin populations (by the application of 
an rf pulse) whereas the Zeeman energy levels (magnetic energy levels, see Paper IV for 
further details) are left unperturbed. In the FFC relaxometry, the spacing between the Zeeman 
energy levels is changed (by varying the applied magnetic fields) without disturbing the spin 
populations. However, both methods provide the same information as the relaxation 
mechanisms do not depend on how the non-equilibrium state is created. 
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Figure 28: Schematic representations of the two basic FFC relaxometric techniques: (a) with and (b) without the 
prepolarisation fields. In both (a) and (b), the variation of the applied magnetic field is shown at the top and the 
evolution of the magnetisation during the measurement is shown at the bottom.  
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Chapter 5. Summary of Results, Conclusions and 
Directions for Future Research 
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In this chapter, a brief summary of the various studies that constitute this thesis is presented. 
To improve coherency and avoid repetition, Papers I – V are discussed in the order of the 
‘phases’ introduced in Section 1.5, and thus may not necessarily follow their chronological 
order.  
5.1 Two-Spin Relaxation Theory 
Paper IV forms the basis of the first phase i.e., the development of a theoretical model for 
MRI CAs. 
As discussed in Chapter 4, the theoretical framework for MRI CAs is based on a two-spin 
model, where the electronic spin of the Gd(III) metal ion is coupled with the proton (or 
oxygen) nuclear spin of the coordinated water molecule. To thoroughly understand the effect 
of various correlation times, τR and τm (Figure 3) in particular, on the relaxivities of an MRI 
CA, it is important to understand their origin and underlying theoretical concepts. However, 
because of the complex terminology and widely scattered information, it is a challenge to 
learn such relaxation theory. Therefore, relaxation theory for the dipolar and scalar relaxation 
mechanisms, pertinent for MRI CAs, was (re)derived in Paper IV in a comprehensive and 
pedagogical manner at a depth not previously presented, including discussing the pertinent 
quantum mechanics, spherical harmonics, stochastic processes and perturbation theories.  
Based on this theoretical understanding, novel supramolecular nanoassemblies made from 
paramagnetic amphiphiles were developed and characterised as advanced MRI CAs, as 
discussed below. 
5.2 Novel Supramolecular MRI Contrast Agents 
In the second, third and fourth phases of this project, two strategies were followed to develop 
highly ordered paramagnetic supramolecular nanoassemblies, as discussed below. 
5.2.1 Incorporation of Paramagnetic Amphiphiles within a Non-Ionic Amphiphilic 
Matrix 
Paper I and Paper II fall in this category. 
As discussed in Section 1.4.2, supramolecular paramagnetic nanoassemblies possess 
favourable properties to be explored as advanced MRI CAs such as slow reorientation, 
extensive water channels (resulting in better water access) and a high payload of Gd(III) 
metal ions. Inverse bicontinuous cubic phases (V2), in particular, have been used as stable 
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drug delivery systems
45, 46, 95
 and therefore, also have the potential to be utilised as the 
carriers for MRI CAs.  
To this end, in Paper I, first the paramagnetic supramolecular nanoassemblies of Gd-DTPA-
monooleyl (Gd-DTPA-MO), a paramagnetic amphiphile, incorporated within glycerol 
monooleyl (GMO), an inverse bicontinuous cubic phase forming non-ionic matrix, at various 
concentrations (Figure 29a), were investigated. The motivation behind this study was to 
obtain supramolecular inverse cubic nanostructures with the highest possible amount of Gd-
DTPA-MO (within GMO) and investigate the effect of nanostructures on the relaxivities of 
Gd-DTPA-MO. It was found that > 5 mole% of Gd-DTPA-MO was disrupting the cubic 
phase geometry of GMO in the bulk phase. Also, when dispersed in water, only the 
dispersions with ≤ 1 mole% Gd-DTPA-MO displayed cubosomes. However, even then, the 
nanoassemblies of the mixed amphiphiles (i.e., Gd-DTPA-MO incorporated within GMO) 
showed better relaxivities at high magnetic field strengths than the nanoassemblies of sole 
Gd-DTPA-MO amphiphiles. When compared to a commercially available non-self-
assembling contrast agent, Magnevist, all the nanoassemblies showed much better contrast at 
both low and high magnetic field strengths. 
From the above results, we aimed at investigating a different system in which the cubic phase 
of the external matrix is retained at higher concentrations of Gd-amphiphiles. Therefore, in 
Paper II, the system of Gd-DTPA-monophytanyl (Gd-DTPA-MP) within the phytantriol (PT) 
cubic phase forming matrix was investigated (Figure 29b). The rationale behind this system 
was twofold. First, instead of using GMO, which has an ester bond and is thus labile at low 
and high pH, PT was used. PT lacks the ester bond but still has very similar phase behaviour 
to GMO.
96
 Also, contrary to Gd-DTPA-MO, which was previously shown to form mostly 
micellar nanoassemblies,
97
 Gd-DTPA-MP was used, which forms liposomal nanoassemblies 
by itself. This suggests that the latter induces less positive curvature (i.e., less curvature 
towards the hydrophobic chains, see Section 1.4.2) conducing to its incorporation at a higher 
concentration within PT before disrupting the cubic mesophases. Moreover, Gd-DTPA-MP 
was shown to possess lower in vitro cytotoxicity than Gd-DTPA-MO.
41
 Upon investigation, 
the above premisses were confirmed, as reported and discussed in Paper II. 
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Figure 29: Chemical structures of the two amphiphilic systems investigated as supramolecular MRI contrast 
agents. In (a) Gd-DTPA-MO was incorporated within glycerol monooleyl whereas in (b) Gd-DTPA-MP was 
integrated within phytantriol. In the latter system, the cubic mesophases of the non-ionic lipid were retained at a 
higher concentration of the incorporated Gd-amphiphile. 
 
5.2.2 Novel Paramagnetic Amphiphiles with High Critical Packing Parameter 
Details on this strategy can be found in Paper III.  
In an attempt to develop supramolecular MRI CAs with highly ordered nanostructures, made 
solely from paramagnetic amphiphiles (i.e., without incorporating them within any external 
matrix), we set out to design paramagnetic amphiphiles with a relatively high CPP (Eq. (2)
Figure 6, Section 1.4.2). To this end, based on the results of Paper II, a new amphiphilic MRI 
CA was designed, a Gd(III) chelated DTPA conjugated to two branched aliphatic phytanyl 
chains via a rigid dopamine spacer molecule, Gd-DTPA-dopamine-bisphytanyl (Gd-DTPA-
Dop-Phy) (Figure 30). It was postulated that with higher effective volume of hydrophobic 
chains (due to two branched alkyl chains and the hydrophobic spacer, dopamine), Gd-DTPA-
Dop-Phy should have a higher CPP (Eq. (2)) while still retaining one negative charge for 
efficient hydration of the head-group. However, the liquid crystalline structures of Gd-
DTPA-Dop-Phy were revealed to be lamellar phases in bulk by both POM and SAXS 
analyses. Consequently, upon dispersion in aqueous solution, liposomal nanoassemblies were 
formed, as confirmed by SAXS and cryo-TEM.  
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Figure 30: Chemical structure of Gd-DTPA-Dop-Phy, a paramagnetic amphiphile with two branched aliphatic 
phytanyl chains conjugated to Gd(III) chelated DTPA via a rigid dopamine spacer, with a relatively high critical 
packing parameter. 
 
As discussed in Section 1.5, in the last phase of the project, to understand the effect of 
amphiphile design and the formation of nanostructures on relaxation (or molecular) 
parameters, variable temperature 
17
O NMR transverse relaxation measurements and 
1
H 
NMRD profiles (from FFC relaxometric experiments) were also conducted. The theoretical 
model based on the two-spin system, as discussed in Paper IV and Chapter 4, was then 
compared to the experimental results to deduce relaxation parameters such as τm and τR. 
These experiments revealed that the relaxation enhancement of the Gd-DTPA-Dop-Phy 
liposomal nanoassemblies was limited by water exchange. However, compared to the 
previously reported paramagnetic liposomes (phospholipid liposomes with partially 
incorporated Gd-complexed amphiphiles),
98-100
 water exchange in the Gd-DTPA-Dop-Phy 
liposomal nanoassemblies was found to be faster.  
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5.3 Fast Relaxivity Measurements 
As discussed in Section 2.4.3, longitudinal and transverse relaxivities of an MRI CA can be 
determined from the slopes of the linear fits of the 1/Ti versus [CA] plots. This usually entails 
a large number of relaxation measurements especially for self-assembly systems discussed in 
Section 5.2. Moreover, for accurate relaxivity measurements, the dilutions are then usually 
subject to inductively couple plasma (ICP) mass spectrometry (MS) measurements to 
determine their exact Gd(III) concentrations, which can be laborious and expensive.  
To this end, in Paper V, a new method was proposed and investigated to accelerate the 
process of characterising relaxivities of MRI CAs by relating the two NMR observables: 
induced chemical shifts and enhanced relaxation rates, both of which are dependent on the 
concentration of a paramagnetic MRI CA. For Magnevist, in which there was no significant 
spectral overlap between the peaks of different dilutions, the relaxivity was able to be 
determined from a single measurement, with simultaneous relaxation time measurements of 
up to five dilutions and without determining exact concentrations using ICP methods. The use 
of biexponential fitting to reduce the experimental time for determining 
1
H relaxivities in 
systems (MRI CAs) with significant spectral overlap was also suggested and validated. 
 
5.4 General Conclusions and Directions for Future Research 
In this work, novel supramolecular nanoassemblies made of paramagnetic amphiphiles have 
been developed and their potential as advanced MRI CAs investigated. In doing so, an 
attempt has been made to bridge the gap between the theory and experiments by discussing 
the underlying relaxation mechanisms and pedagogically (re)deriving the most commonly 
used theoretical model to analyse and predict relaxivities at various fields or temperatures. 
The paramagnetic amphiphilic systems designed, synthesised and investigated in this thesis 
have shown high potential to be used as advanced MRI CAs. In particular, it was shown that 
upon dispersion in an aqueous solution, sole paramagnetic amphiphiles can form stable 
liposomal nanoassemblies and can be successfully incorporated within non-ionic lipid 
matrices to form higher order mesophases such as inverse cubosomal nanoassemblies. Such 
paramagnetic nanoassemblies offer high payloads of Gd(III) ions, possess slow molecular 
reorientation (resulting in improved relaxivities) and are also passively targeted to tumour 
cells (although their passive targeting ability was beyond the scope of this thesis and wasn’t 
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assessed). By comparing the theoretical models with the experimental data, it was confirmed 
that the relaxivity enhancement of these nanoassemblies were limited by their slow water 
exchange. 
For better relaxivities, new amphiphilic chelates need to be designed with faster water 
exchange rates. This can be addressed by employing a similar strategy, as used in Paper I – 
Paper III, to chelating agents other than DTPA, which have been reported to possess fast 
water exchange, such as the recently reported Gd-DOTA-APSA.
101
 Also, the “click”  
chemistry reaction can be used to impart the amphiphilic character to the paramagnetic 
chelate while avoiding the amide linkage, which is known to exhibit slower water 
exchange.
102
  
New theoretical models that can account for multiple water exchange rates possible in the 
supramolecular nanoassemblies (see Paper III) and are also applicable for non-rigid 
molecules (see ‘Notes’ in Paper IV) need to be developed for better analysis and 
understanding of their relaxation behaviour. Note, however, that for such complicated 
systems, it becomes difficult to use the superposition state formalism and the energy level 
populations, as discussed in Paper IV, and a more general approach developed by Wangsness, 
Bloch and Redfield (known as the WBR or Redfield theory) is required.
103-105
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